Premium
Dianthus Therapeutics Inc (DNTH)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 7 767 686 | 14,21% | US$ 660,02M | 2026-03-31 |
| BlackRock, Inc. | Institution | 3 175 677 | 5,81% | US$ 269,84M | 2026-03-31 |
| Point72 Associates, LLC | Institution | 2 981 674 | 5,45% | US$ 253,35M | 2026-02-13 |
| RA Capital Healthcare Fund, L.P. | Institution | 2 866 733 | 5,24% | US$ 243,59M | 2025-09-30 |
| RA Capital Management, L.P. | Institution | 2 611 733 | 4,78% | US$ 221,92M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 2 595 783 | 4,75% | US$ 220,56M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 2 537 191 | 4,64% | US$ 215,59M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 2 439 130 | 4,46% | US$ 207,25M | 2026-03-31 |
| Sirenia Capital Management LP | Institution | 2 298 122 | 4,20% | US$ 195,27M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 2 137 191 | 3,91% | US$ 181,60M | 2025-11-21 |
| Avidity Partners Management, L.P. | Institution | 2 104 184 | 3,85% | US$ 178,79M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 2 031 249 | 3,72% | US$ 172,60M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 1 946 667 | 3,56% | US$ 165,41M | 2026-03-31 |
| Octagon Investments Master Fund LP | Institution | 1 818 500 | 3,33% | US$ 154,52M | 2024-12-31 |
| TCG Crossover Management, LLC | Institution | 1 676 624 | 3,07% | US$ 142,46M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 610 483 | 2,95% | US$ 136,84M | 2026-03-31 |
| TCG Crossover Fund II, L.P. | Institution | 1 501 624 | 2,75% | US$ 127,59M | 2025-03-31 |
| Tellus BioVentures, LLC | Institution | 1 436 745 | 2,63% | US$ 122,08M | 2025-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 398 913 | 2,56% | US$ 118,87M | 2026-03-31 |
| Bain Capital Life Sciences Fund III, L.P. | Institution | 1 315 892 | 2,41% | US$ 111,81M | 2025-09-30 |
| 5AM Ventures VII, L.P. | Institution | 1 231 619 | 2,25% | US$ 104,65M | 2024-09-30 |
| VR Management, LLC | Institution | 1 180 000 | 2,16% | US$ 100,26M | 2026-03-31 |
| Fred Alger Management, LLC | Institution | 1 161 923 | 2,13% | US$ 98,73M | 2026-03-31 |
| Polar Capital Holdings Plc | Institution | 1 076 009 | 1,97% | US$ 91,43M | 2026-03-31 |
| Deerfield Management Company, L.P. | Institution | 1 019 813 | 1,87% | US$ 86,65M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 961 585 | 1,76% | US$ 81,71M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 950 000 | 1,74% | US$ 80,72M | 2026-03-31 |
| AllianceBernstein L.P. | Institution | 926 071 | 1,69% | US$ 78,69M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 916 211 | 1,68% | US$ 77,85M | 2026-03-31 |
| Braidwell LP | Institution | 899 364 | 1,65% | US$ 76,42M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 852 164 | 1,56% | US$ 72,41M | 2026-03-31 |
| UBS Asset Management AG | Institution | 841 717 | 1,54% | US$ 71,52M | 2026-03-31 |
| Farallon Capital Management, L.L.C. | Institution | 836 000 | 1,53% | US$ 71,03M | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 654 746 | 1,20% | US$ 55,63M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 643 599 | 1,18% | US$ 54,69M | 2026-03-31 |
| Catalio Capital Management, LP | Institution | 560 308 | 1,02% | US$ 47,61M | 2026-03-31 |
| Jennison Associates LLC | Institution | 485 136 | 0,89% | US$ 41,22M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 474 085 | 0,87% | US$ 40,28M | 2026-03-31 |
| Woodline Partners LP | Institution | 433 457 | 0,79% | US$ 36,83M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
